Back to results
US 2025/0152597 A1Published application
Linezolid formulations
AssigneePersica Pharmaceuticals Ltd.
InventorsLloyd Czaplewski, Sarah Guest
Life of this patent
Estimating the term…
Abstract
The present invention relates to injectable, thermosensitive hydrogel compositions comprising linezolid for relieving and/or treating chronic low back pain (CLBP).
Claims28
An injectable pharmaceutical formulation comprising:
- (a) an effective amount of linezolid,
- (b) a thermosensitive hydrogel comprising poloxamer and iohexol, and optionally
- (c) at least one pharmaceutically acceptable excipient,
- wherein linezolid forms a suspension in the thermosensitive hydrogel.
1 more element
An injectable pharmaceutical formulation comprising about 2.5 to 20% linezolid form II, about 17% to 30% iohexol, and about 10.8% to 12.8% poloxamer by weight of the formulation.
An injectable linezolid formulation comprising:
- (a) a linezolid Form II powder,
- (b) a thermosensitive hydrogel comprising poloxamer 407 and iohexol, and optionally
- (c) at least one excipient,
- wherein said linezolid formulation is prepared through the method comprising:
- (i) milling linezolid form II to a defined powder,
- (ii) preparing a unit of linezolid powder from step (i) and sterilizing the preparation,
- (iii) preparing and sterilizing the thermosensitive hydrogel comprising poloxamer 407 and iohexol, and
- (iv) suspending said linezolid powder from step (ii) in the thermosensitive hydrogel from step (iii).
5 more elements
A kit comprising:
- (a) a linezolid Form II powder, and
- (b) a thermosensitive hydrogel comprising poloxamer 407 and iohexol.
A thermosensitive hydrogel for drug delivery comprising:
- (a) poloxamer 407 which is present in the hydrogel at a concentration of about 10% to about 17% by weight of the hydrogel;
- and
- (b) Iohexol which is present in the hydrogel at a concentration of about 14.5% to about 62.5% by weight of the hydrogel,
- wherein the hydrogel forms gel at a temperature between 26° C. and 36° C.
1 more element
Dependencies are inferred from the claim text.